Frontlight ResearchEarly access
Melanoma trials in Australia
46 of 49 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleDuration of Anti-PD-1 Therapy in Metastatic Melanoma
- Where
- Birtinya, Cairns, Clayton, Coffs Harbour, Herston, Melbourne, Southport, Victoria, Waratah, Westmead, Woodville
- Age
- 18 years and over
- People
- 614 worldwide
- Run by
- Canadian Cancer Trials Group
See details and how to joinNCT02821013 - Phase 3Not yet taking people in AustraliaStudy of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
- Where
- Melbourne, Woolloongabba
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07804186 - Phase 1/2Taking peopleSafety and Efficacy of OBX-115 in Advanced Solid Tumors
- Where
- Wollstonecraft
- Age
- 18 years and over
- People
- 254 worldwide
- Run by
- Obsidian Therapeutics, Inc.
See details and how to joinNCT06060613 - Early phase 1Taking people177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
- Where
- Adelaide, Gosford, Kingswood, Murdoch, Southport, Wollongong
- Age
- 18 years and over
- People
- 30
- Run by
- Radiopharm Theranostics, Ltd
See details and how to joinNCT06305962 - Phase 2Taking peopleDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Where
- Adelaide, Benowa, Birtinya, North Sydney
- Age
- 18 years and over
- People
- 750 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00 - Phase 2Taking peoplePsilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
- Where
- Abbotsford, Leederville, Melbourne, Northcote
- Age
- 18 years to 80 years
- People
- 87
- Run by
- Psyence Australia Pty Ltd
See details and how to joinNCT07072728 - Phase 1Taking peopleA Study of MGC026 in Participants With Advanced Solid Tumors
- Where
- Auchenflower, Heidelberg, Kurralta Park
- Age
- 18 years and over
- People
- 394 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06242470 - Phase 1/2Taking peoplePhase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
- Where
- Wollstonecraft
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Strand Therapeutics Inc.
See details and how to joinNCT07751042 - Phase 2Taking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Camperdown, Chermside, Clayton, Hobart, Hyde Park
- Age
- 18 years and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Blacktown, Mount Kuring-Gai, St Leonards, Subiaco, Woolloongabba
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 2Taking peopleThe Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma
- Where
- Cairns, Greenslopes, Melbourne, Nedlands, Waratah, Woolloongabba
- Age
- 18 years and over
- People
- 48
- Run by
- Primmune Therapeutics, Inc.
See details and how to joinNCT07565285 - Phase 1/2Taking peopleA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Where
- Birtinya, Blacktown, Brisbane, Camperdown, Concord, Gold Coast, Nedlands, New Lambton Heights, Sydney, Waratah
- Age
- 18 years and over
- People
- 862 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05914116 - Phase 1/2Taking peopleIntratumoral N17350 in Advanced Solid Tumors
- Where
- Melbourne, Newcastle, Westmead
- Age
- 18 years and over
- People
- 275 worldwide
- Run by
- Onchilles Pharma Inc
See details and how to joinNCT07339176 - Phase 1/2Taking peopleBevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases
- Where
- Melbourne
- Age
- 18 years and over
- People
- 46
- Run by
- Melanoma and Skin Cancer Trials Limited
See details and how to joinNCT06163820 - Phase 1/2Taking peopleA Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Where
- Adelaide, Blacktown, Darlinghurst, Frankston, Heidelberg, Melbourne, Nedlands, Southport, Wollstonecraft
- Age
- 18 years and over
- People
- 1,438 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07070232 · EU 2024-517261-16-00 - Phase 2Taking peopleAnti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)
- Where
- Adelaide, East Melbourne, Melbourne, Perth, Sydney, Waratah, Wollstonecraft, Woolloongabba
- Age
- 18 years to 120 years
- People
- 218 worldwide
- Run by
- Melanoma Institute Australia
See details and how to joinNCT03340129 · EU 2024-518545-13-00 - Phase 1/2Taking peopleA Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Where
- East Melbourne
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07115043 - Phase 2/3Taking peopleSafety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Where
- Bedford Park, Box Hill, Chermside, Frankston, Wollongong
- Age
- 18 years and over
- People
- 740 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00 - Phase 3Taking peopleStudy to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- Where
- Bedford Park, Greenslopes, Melbourne, Murdoch, Westmead
- Age
- 18 years to 70 years
- People
- 670 worldwide
- Run by
- Iovance Biotherapeutics, Inc.
See details and how to joinNCT05727904 · EU 2022-503140-41-00 - Phase 1/2Taking peopleStudy of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Where
- Bedford Park, Clayton, Frankston, Heidelberg, Melbourne, Miranda, Saint Albans
- Age
- 18 years and over
- People
- 159 worldwide
- Run by
- Aulos Bioscience, Inc.
See details and how to joinNCT05267626 - Phase 3Taking peopleStudy of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
- Where
- Darlinghurst, Fremantle, South Yarra, Westmead, Woolloongabba
- Age
- 18 years and over
- People
- 369 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06585410 - Phase 1/2Taking peopleSL-28 for Advanced Solid Tumours
- Where
- Adelaide, Gold Coast, Sydney
- Age
- 18 years and over
- People
- 60
- Run by
- Second Life Therapeutics
See details and how to joinNCT07341737 - Phase 1Taking peopleA Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
- Where
- Heidelberg, Perth, Southport, Waratah, Wollstonecraft
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT04913285 - Phase 1/2Taking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Blacktown, Brisbane, Liverpool, Malvern, Melbourne, Nedlands
- Age
- 18 years and over
- People
- 1,109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - Phase 1Taking peopleIDOV-Immune for Advanced Solid Tumors
- Where
- Melbourne, Westmead
- Age
- 18 years and over
- People
- 78 worldwide
- Run by
- ViroMissile, Inc.
See details and how to joinNCT06910657